These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1229508)

  • 21. [Valve replacement or valvuloplasty, which one to choose?].
    Limet R
    Rev Med Liege; 1984 May; 39(9):362-4. PubMed ID: 6729307
    [No Abstract]   [Full Text] [Related]  

  • 22. Ten years experience with the Ionescu-Shiley pericardial xenograft heart valve.
    Ionescu MI; Chidambaram M; Hasan SS; Tandon AP; Smith DR
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Apr; 30(4):488-502. PubMed ID: 7119515
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of the remote results of valve substitution with artificial prostheses].
    De Vita C; Pellegrini A; Formentini A; Brusoni B; Cadel A; Peronace B; Ricci A
    Atti Soc Ital Cardiol; 1970; 2():427-68. PubMed ID: 5478904
    [No Abstract]   [Full Text] [Related]  

  • 24. Total prosthetic valve replacement in children under 10-years of age.
    Taguchi K
    Can Med Assoc J; 1968 Apr; 98(16):765-9. PubMed ID: 5689554
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term results of mechanical valve replacement: isolated mitral valve replacement and mitral-aortic valve replacement.
    Remadi JP; Duveau D
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S26. PubMed ID: 15224996
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mitral valve and aortic valve diseases--valvoplasty and valve replacement].
    Asano K
    Nihon Rinsho; 1978 May; Suppl():1984-5. PubMed ID: 691597
    [No Abstract]   [Full Text] [Related]  

  • 27. The experience with porcine bioprostheses at Padua University.
    Gerosa G; Rizzoli G; Di Marco F; Bottio T; Thiene G; Casarotto D
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S44-8. PubMed ID: 15225001
    [No Abstract]   [Full Text] [Related]  

  • 28. [Factors influencing surgical technic in the replacement of heart valves with prostheses].
    Muntoni E; Pizzetti F; Del Moro J
    Arch Ital Chir; 1969; 95(1):5-27. PubMed ID: 5407528
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging transcatheter therapies for aortic and mitral disease.
    Christofferson RD; Kapadia SR; Rajagopal V; Tuzcu EM
    Heart; 2009 Feb; 95(2):148-55. PubMed ID: 18519552
    [No Abstract]   [Full Text] [Related]  

  • 30. [Heart valve prosthesis. Long-term results for the internist's viewpoint].
    Klein WW; Kraft-Kinz J
    Wien Z Inn Med; 1972; 53(12):630-8. PubMed ID: 4671776
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of radiocinematographic criteria with and without contrast media in the diagnosis of malfunction and complications of cardiac valve prostheses].
    Stritoni P; Rubino A; Scognamiglio R; Razzolini R; Daliento L; Corbara F; Valfrè C; Chioin R
    Boll Soc Ital Cardiol; 1981; 26(9):819-26. PubMed ID: 7052103
    [No Abstract]   [Full Text] [Related]  

  • 32. Heart valve replacement in children with the Björk-Shiley prosthesis.
    Figuera D; Zavanella C; Rufilanchas JJ; Téllez G; Agosti J
    J Cardiovasc Surg (Torino); 1974; 15(5):510-5. PubMed ID: 4279922
    [No Abstract]   [Full Text] [Related]  

  • 33. Issues concerning the clinical evaluation of new prosthetic valves.
    Gersh BJ; Fisher LD; Schaff HV; Rahimtoola SH; Reeder GS; Frater RW; McGoon DC
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):460-6. PubMed ID: 3512921
    [No Abstract]   [Full Text] [Related]  

  • 34. Eight years of experience with the Björk-Shiley tilting disc valve prosthesis in 833 patients.
    Walter P; Schwarz F; Scheld H; Hehrlein FW
    Thorac Cardiovasc Surg; 1979 Jun; 27(3):178-86. PubMed ID: 462467
    [No Abstract]   [Full Text] [Related]  

  • 35. What is the current status of prosthetic cardiac valve replacement?
    Matloff JM; Chaux A
    Cardiovasc Clin; 1977; 8(1):241-68. PubMed ID: 849594
    [No Abstract]   [Full Text] [Related]  

  • 36. [Late thromboembolic complications after the surgical correction of mitral-aortic-tricuspid heart defects].
    Dubrovskiĭ VS; Pospelova EP; Nazarenko VP; Iaroshinskiĭ IuN
    Sov Med; 1984; (6):17-22. PubMed ID: 6463743
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac valve replacement. A seven-year follow-up.
    Aston SJ; Mulder DG
    J Thorac Cardiovasc Surg; 1971 Apr; 61(4):547-55. PubMed ID: 5549110
    [No Abstract]   [Full Text] [Related]  

  • 38. Five-years actuarial analysis after heart valve replacement with the St. Jude medical prosthesis.
    Fraedrich G; Höge R; Fiedler R; Hehrlein FW
    Z Kardiol; 1986; 75 Suppl 2():282-5. PubMed ID: 3727702
    [No Abstract]   [Full Text] [Related]  

  • 39. Emerging transcatheter therapies for aortic and mitral disease.
    Messori A; Trippoli S
    Heart; 2009 Oct; 95(20):1707. PubMed ID: 19786707
    [No Abstract]   [Full Text] [Related]  

  • 40. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.